Serum  ||| S:0 E:6 ||| NNP
amyloid  ||| S:6 E:14 ||| VBD
A  ||| S:14 E:16 ||| DT
level  ||| S:16 E:22 ||| NN
as  ||| S:22 E:25 ||| IN
a  ||| S:25 E:27 ||| DT
potential  ||| S:27 E:37 ||| JJ
indicator  ||| S:37 E:47 ||| NN
of  ||| S:47 E:50 ||| IN
the  ||| S:50 E:54 ||| DT
status  ||| S:54 E:61 ||| NN
of  ||| S:61 E:64 ||| IN
endurance  ||| S:64 E:74 ||| JJ
horses  ||| S:74 E:81 ||| NNS
Changes  ||| S:81 E:89 ||| NNS
in  ||| S:89 E:92 ||| IN
serum  ||| S:92 E:98 ||| JJ
levels  ||| S:98 E:105 ||| NNS
of  ||| S:105 E:108 ||| IN
acute  ||| S:108 E:114 ||| JJ
phase  ||| S:114 E:120 ||| NN
proteins  ||| S:120 E:129 ||| NNS
( ||| S:129 E:130 ||| -LRB-
APPs ||| S:130 E:134 ||| NNP
)  ||| S:134 E:136 ||| -RRB-
reflect  ||| S:136 E:144 ||| VBP
the  ||| S:144 E:148 ||| DT
acute  ||| S:148 E:154 ||| JJ
phase  ||| S:154 E:160 ||| NN
reaction ||| S:160 E:168 ||| NN
,  ||| S:168 E:170 ||| ,
a  ||| S:170 E:172 ||| DT
rapid  ||| S:172 E:178 ||| JJ
and  ||| S:178 E:182 ||| CC
nonspecific  ||| S:182 E:194 ||| JJ
response  ||| S:194 E:203 ||| NN
to  ||| S:203 E:206 ||| TO
any  ||| S:206 E:210 ||| DT
tissue  ||| S:210 E:217 ||| NN
damage ||| S:217 E:223 ||| NN
.  ||| S:223 E:225 ||| .
Serum  ||| S:225 E:231 ||| NNP
amyloid  ||| S:231 E:239 ||| VBD
A  ||| S:239 E:241 ||| DT
( ||| S:241 E:242 ||| -LRB-
SAA ||| S:242 E:245 ||| NNP
)  ||| S:245 E:247 ||| -RRB-
is  ||| S:247 E:250 ||| VBZ
the  ||| S:250 E:254 ||| DT
main  ||| S:254 E:259 ||| JJ
APP  ||| S:259 E:263 ||| NN
in  ||| S:263 E:266 ||| IN
horses ||| S:266 E:272 ||| NNS
,  ||| S:272 E:274 ||| ,
which  ||| S:274 E:280 ||| WDT
increases  ||| S:280 E:290 ||| VBZ
in  ||| S:290 E:293 ||| IN
various  ||| S:293 E:301 ||| JJ
diseases ||| S:301 E:309 ||| NNS
,  ||| S:309 E:311 ||| ,
surgical  ||| S:311 E:320 ||| JJ
injuries  ||| S:320 E:329 ||| NNS
and  ||| S:329 E:333 ||| CC
after  ||| S:333 E:339 ||| IN
long  ||| S:339 E:344 ||| JJ
distance  ||| S:344 E:353 ||| NN
endurance  ||| S:353 E:363 ||| NN
rides ||| S:363 E:368 ||| NNS
;  ||| S:368 E:370 ||| :
however ||| S:370 E:377 ||| RB
,  ||| S:377 E:379 ||| ,
this  ||| S:379 E:384 ||| DT
nonspecific  ||| S:384 E:396 ||| JJ
parameter  ||| S:396 E:406 ||| NN
has  ||| S:406 E:410 ||| VBZ
not  ||| S:410 E:414 ||| RB
been  ||| S:414 E:419 ||| VBN
investigated  ||| S:419 E:432 ||| VBN
as  ||| S:432 E:435 ||| IN
an  ||| S:435 E:438 ||| DT
indicator  ||| S:438 E:448 ||| NN
of  ||| S:448 E:451 ||| IN
subclinical  ||| S:451 E:463 ||| JJ
disorders ||| S:463 E:472 ||| NNS
,  ||| S:472 E:474 ||| ,
which  ||| S:474 E:480 ||| WDT
may  ||| S:480 E:484 ||| MD
result  ||| S:484 E:491 ||| VB
in  ||| S:491 E:494 ||| IN
elimination  ||| S:494 E:506 ||| NN
during  ||| S:506 E:513 ||| IN
endurance  ||| S:513 E:523 ||| JJ
competitions ||| S:523 E:535 ||| NNS
.  ||| S:535 E:537 ||| .
To  ||| S:537 E:540 ||| TO
evaluate  ||| S:540 E:549 ||| VB
the  ||| S:549 E:553 ||| DT
serum  ||| S:553 E:559 ||| JJ
concentration  ||| S:559 E:573 ||| NN
of  ||| S:573 E:576 ||| IN
SAA  ||| S:576 E:580 ||| NNP
as  ||| S:580 E:583 ||| IN
a  ||| S:583 E:585 ||| DT
potential  ||| S:585 E:595 ||| JJ
indicator  ||| S:595 E:605 ||| NN
for  ||| S:605 E:609 ||| IN
the  ||| S:609 E:613 ||| DT
status  ||| S:613 E:620 ||| NN
of  ||| S:620 E:623 ||| IN
horses  ||| S:623 E:630 ||| NNS
prepared  ||| S:630 E:639 ||| VBN
for  ||| S:639 E:643 ||| IN
long  ||| S:643 E:648 ||| JJ
distance  ||| S:648 E:657 ||| NN
endurance  ||| S:657 E:667 ||| NN
rides  ||| S:667 E:673 ||| NNS
( ||| S:673 E:674 ||| -LRB-
120  ||| S:674 E:678 ||| CD
and  ||| S:678 E:682 ||| CC
160  ||| S:682 E:686 ||| CD
km ||| S:686 E:688 ||| CD
) ||| S:688 E:689 ||| -RRB-
.  ||| S:689 E:691 ||| .
Twenty  ||| S:691 E:698 ||| NNP
Arabian  ||| S:698 E:706 ||| NNP
horses  ||| S:706 E:713 ||| NNS
were  ||| S:713 E:718 ||| VBD
tested  ||| S:718 E:725 ||| VBN
and  ||| S:725 E:729 ||| CC
12  ||| S:729 E:732 ||| CD
were  ||| S:732 E:737 ||| VBD
eliminated  ||| S:737 E:748 ||| VBN
during  ||| S:748 E:755 ||| IN
the  ||| S:755 E:759 ||| DT
ride  ||| S:759 E:764 ||| NN
and  ||| S:764 E:768 ||| CC
8  ||| S:768 E:770 ||| CD
completed  ||| S:770 E:780 ||| VBD
the  ||| S:780 E:784 ||| DT
distances ||| S:784 E:793 ||| NN
.  ||| S:793 E:795 ||| .
Routine  ||| S:795 E:803 ||| JJ
haematological  ||| S:803 E:818 ||| NN
and  ||| S:818 E:822 ||| CC
biochemical  ||| S:822 E:834 ||| JJ
tests  ||| S:834 E:840 ||| NNS
and  ||| S:840 E:844 ||| CC
measurement  ||| S:844 E:856 ||| NN
of  ||| S:856 E:859 ||| IN
serum  ||| S:859 E:865 ||| JJ
concentrations  ||| S:865 E:880 ||| NNS
of  ||| S:880 E:883 ||| IN
SAA  ||| S:883 E:887 ||| NNP
were  ||| S:887 E:892 ||| VBD
carried  ||| S:892 E:900 ||| VBN
out  ||| S:900 E:904 ||| RP
before  ||| S:904 E:911 ||| IN
and  ||| S:911 E:915 ||| CC
after  ||| S:915 E:921 ||| IN
the  ||| S:921 E:925 ||| DT
competition ||| S:925 E:936 ||| NN
.  ||| S:936 E:938 ||| .
Results  ||| S:938 E:946 ||| NNS
were  ||| S:946 E:951 ||| VBD
compared  ||| S:951 E:960 ||| VBN
using  ||| S:960 E:966 ||| VBG
the  ||| S:966 E:970 ||| DT
Mann  ||| S:970 E:975 ||| NNP
Whitney  ||| S:975 E:983 ||| NNP
U  ||| S:983 E:985 ||| NNP
test ||| S:985 E:989 ||| NN
.  ||| S:989 E:991 ||| .
Before  ||| S:991 E:998 ||| IN
the  ||| S:998 E:1002 ||| DT
competition  ||| S:1002 E:1014 ||| NN
all  ||| S:1014 E:1018 ||| DT
haematological  ||| S:1018 E:1033 ||| NN
and  ||| S:1033 E:1037 ||| CC
biochemical  ||| S:1037 E:1049 ||| JJ
parameters  ||| S:1049 E:1060 ||| NNS
varied  ||| S:1060 E:1067 ||| VBN
within  ||| S:1067 E:1074 ||| IN
reference  ||| S:1074 E:1084 ||| NN
ranges  ||| S:1084 E:1091 ||| NNS
with  ||| S:1091 E:1096 ||| IN
no  ||| S:1096 E:1099 ||| DT
differences  ||| S:1099 E:1111 ||| NNS
between  ||| S:1111 E:1119 ||| IN
the  ||| S:1119 E:1123 ||| DT
eliminated  ||| S:1123 E:1134 ||| JJ
horses  ||| S:1134 E:1141 ||| NNS
and  ||| S:1141 E:1145 ||| CC
the  ||| S:1145 E:1149 ||| DT
ones  ||| S:1149 E:1154 ||| NNS
that  ||| S:1154 E:1159 ||| WDT
successfully  ||| S:1159 E:1172 ||| RB
finished  ||| S:1172 E:1181 ||| VBD
the  ||| S:1181 E:1185 ||| DT
competition ||| S:1185 E:1196 ||| NN
.  ||| S:1196 E:1198 ||| .
After  ||| S:1198 E:1204 ||| IN
the  ||| S:1204 E:1208 ||| DT
rides  ||| S:1208 E:1214 ||| NNS
creatine  ||| S:1214 E:1223 ||| VBP
phosphokinase  ||| S:1223 E:1237 ||| JJ
activity  ||| S:1237 E:1246 ||| NN
and  ||| S:1246 E:1250 ||| CC
neutrophil ||| S:1250 E:1260 ||| NNS
:  ||| S:1260 E:1262 ||| :
lymphocyte  ||| S:1262 E:1273 ||| JJ
ratio  ||| S:1273 E:1279 ||| NN
reflecting  ||| S:1279 E:1290 ||| VBG
exercise-induced  ||| S:1290 E:1307 ||| JJ
leukogram  ||| S:1307 E:1317 ||| JJ
changes  ||| S:1317 E:1325 ||| NNS
increased  ||| S:1325 E:1335 ||| VBD
( ||| S:1335 E:1336 ||| -LRB-
P  ||| S:1336 E:1338 ||| NNP
< ||| S:1338 E:1340 ||| SYM
0.05 ||| S:1340 E:1344 ||| CD
)  ||| S:1344 E:1346 ||| -RRB-
in  ||| S:1346 E:1349 ||| IN
both  ||| S:1349 E:1354 ||| DT
groups ||| S:1354 E:1360 ||| NNS
.  ||| S:1360 E:1362 ||| .
Before  ||| S:1362 E:1369 ||| IN
the  ||| S:1369 E:1373 ||| DT
competition ||| S:1373 E:1384 ||| NN
,  ||| S:1384 E:1386 ||| ,
the  ||| S:1386 E:1390 ||| DT
concentration  ||| S:1390 E:1404 ||| NN
of  ||| S:1404 E:1407 ||| IN
SAA  ||| S:1407 E:1411 ||| NNP
remained  ||| S:1411 E:1420 ||| VBD
within  ||| S:1420 E:1427 ||| IN
reference  ||| S:1427 E:1437 ||| NN
ranges ||| S:1437 E:1443 ||| NNS
;  ||| S:1443 E:1445 ||| :
however ||| S:1445 E:1452 ||| RB
,  ||| S:1452 E:1454 ||| ,
it  ||| S:1454 E:1457 ||| PRP
was  ||| S:1457 E:1461 ||| VBD
significantly  ||| S:1461 E:1475 ||| RB
( ||| S:1475 E:1476 ||| -LRB-
P  ||| S:1476 E:1478 ||| NNP
< ||| S:1478 E:1480 ||| SYM
0.05 ||| S:1480 E:1484 ||| CD
)  ||| S:1484 E:1486 ||| -RRB-
lower  ||| S:1486 E:1492 ||| JJR
in  ||| S:1492 E:1495 ||| IN
horses  ||| S:1495 E:1502 ||| NNS
that  ||| S:1502 E:1507 ||| WDT
successfully  ||| S:1507 E:1520 ||| RB
finished  ||| S:1520 E:1529 ||| VBD
the  ||| S:1529 E:1533 ||| DT
competition  ||| S:1533 E:1545 ||| NN
than  ||| S:1545 E:1550 ||| IN
in  ||| S:1550 E:1553 ||| IN
eliminated  ||| S:1553 E:1564 ||| JJ
ones  ||| S:1564 E:1569 ||| NNS
( ||| S:1569 E:1570 ||| -LRB-
411.7  ||| S:1570 E:1576 ||| CD
±  ||| S:1576 E:1578 ||| CD
144  ||| S:1578 E:1582 ||| CD
ng ||| S:1582 E:1584 ||| FW
/ ||| S:1584 E:1585 ||| FW
ml  ||| S:1585 E:1588 ||| FW
vs.  ||| S:1588 E:1592 ||| FW
5809.5  ||| S:1592 E:1599 ||| FW
±  ||| S:1599 E:1601 ||| FW
2242.7  ||| S:1601 E:1608 ||| FW
ng ||| S:1608 E:1610 ||| FW
/ ||| S:1610 E:1611 ||| FW
ml ||| S:1611 E:1613 ||| FW
) ||| S:1613 E:1614 ||| -RRB-
.  ||| S:1614 E:1616 ||| .
After  ||| S:1616 E:1622 ||| IN
the  ||| S:1622 E:1626 ||| DT
ride  ||| S:1626 E:1631 ||| NN
SAA  ||| S:1631 E:1635 ||| NN
levels  ||| S:1635 E:1642 ||| NNS
increased  ||| S:1642 E:1652 ||| VBD
( ||| S:1652 E:1653 ||| -LRB-
P  ||| S:1653 E:1655 ||| NNP
< ||| S:1655 E:1657 ||| SYM
0.05 ||| S:1657 E:1661 ||| CD
)  ||| S:1661 E:1663 ||| -RRB-
and  ||| S:1663 E:1667 ||| CC
were  ||| S:1667 E:1672 ||| VBD
similar  ||| S:1672 E:1680 ||| JJ
in  ||| S:1680 E:1683 ||| IN
both  ||| S:1683 E:1688 ||| DT
groups  ||| S:1688 E:1695 ||| NNS
( ||| S:1695 E:1696 ||| -LRB-
13,833.8  ||| S:1696 E:1705 ||| FW
±  ||| S:1705 E:1707 ||| FW
1354.3  ||| S:1707 E:1714 ||| FW
ng ||| S:1714 E:1716 ||| FW
/ ||| S:1716 E:1717 ||| FW
ml  ||| S:1717 E:1720 ||| FW
and  ||| S:1720 E:1724 ||| FW
12,831.2  ||| S:1724 E:1733 ||| FW
±  ||| S:1733 E:1735 ||| FW
1317.6  ||| S:1735 E:1742 ||| FW
ng ||| S:1742 E:1744 ||| FW
/ ||| S:1744 E:1745 ||| FW
ml ||| S:1745 E:1747 ||| FW
) ||| S:1747 E:1748 ||| -RRB-
.  ||| S:1748 E:1750 ||| .
Serum  ||| S:1750 E:1756 ||| NNP
SAA  ||| S:1756 E:1760 ||| NNP
level  ||| S:1760 E:1766 ||| NN
was  ||| S:1766 E:1770 ||| VBD
the  ||| S:1770 E:1774 ||| DT
only  ||| S:1774 E:1779 ||| JJ
laboratory  ||| S:1779 E:1790 ||| NN
parameter  ||| S:1790 E:1800 ||| NNS
that  ||| S:1800 E:1805 ||| WDT
indicated  ||| S:1805 E:1815 ||| VBD
most  ||| S:1815 E:1820 ||| RBS
( ||| S:1820 E:1821 ||| -LRB-
66.6 ||| S:1821 E:1825 ||| CD
% ||| S:1825 E:1826 ||| NN
)  ||| S:1826 E:1828 ||| -RRB-
of  ||| S:1828 E:1831 ||| IN
the  ||| S:1831 E:1835 ||| DT
eliminated  ||| S:1835 E:1846 ||| JJ
horses  ||| S:1846 E:1853 ||| NNS
before  ||| S:1853 E:1860 ||| IN
entering  ||| S:1860 E:1869 ||| VBG
the  ||| S:1869 E:1873 ||| DT
competition ||| S:1873 E:1884 ||| NN
.  ||| S:1884 E:1886 ||| .
None  ||| S:1886 E:1891 ||| NN
of  ||| S:1891 E:1894 ||| IN
the  ||| S:1894 E:1898 ||| DT
horses  ||| S:1898 E:1905 ||| NNS
with  ||| S:1905 E:1910 ||| IN
SAA  ||| S:1910 E:1914 ||| NNP
level  ||| S:1914 E:1920 ||| NN
higher  ||| S:1920 E:1927 ||| JJR
than  ||| S:1927 E:1932 ||| IN
1000  ||| S:1932 E:1937 ||| CD
ng ||| S:1937 E:1939 ||| CD
/ ||| S:1939 E:1940 ||| CD
ml  ||| S:1940 E:1943 ||| NNS
completed  ||| S:1943 E:1953 ||| VBD
the  ||| S:1953 E:1957 ||| DT
distance ||| S:1957 E:1965 ||| NN
.  ||| S:1965 E:1967 ||| .
Thus ||| S:1967 E:1971 ||| RB
,  ||| S:1971 E:1973 ||| ,
it  ||| S:1973 E:1976 ||| PRP
may  ||| S:1976 E:1980 ||| MD
be  ||| S:1980 E:1983 ||| VB
postulated  ||| S:1983 E:1994 ||| VBN
that  ||| S:1994 E:1999 ||| IN
serum  ||| S:1999 E:2005 ||| JJ
SAA  ||| S:2005 E:2009 ||| NNP
concentration  ||| S:2009 E:2023 ||| NN
may  ||| S:2023 E:2027 ||| MD
indicate  ||| S:2027 E:2036 ||| VB
a  ||| S:2036 E:2038 ||| DT
poor  ||| S:2038 E:2043 ||| JJ
status  ||| S:2043 E:2050 ||| NN
of  ||| S:2050 E:2053 ||| IN
a  ||| S:2053 E:2055 ||| DT
horse ||| S:2055 E:2060 ||| NN
,  ||| S:2060 E:2062 ||| ,
resulting  ||| S:2062 E:2072 ||| VBG
in  ||| S:2072 E:2075 ||| IN
elimination  ||| S:2075 E:2087 ||| NN
during  ||| S:2087 E:2094 ||| IN
a  ||| S:2094 E:2096 ||| DT
competition ||| S:2096 E:2107 ||| NN
.  ||| S:2107 E:2109 ||| .
